US Patent Issued to C4 Therapeutics on Jan. 20 for "Heterocyclic compounds for medical treatment" (Swiss, American, French Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,797, issued on Jan. 20, was assigned to C4 Therapeutics Inc..

"Heterocyclic compounds for medical treatment" was invented by Christopher G. Nasveschuk (Stoneham, Mass.), Roger Norcross (Basel, Switzerland), Fabian Dey (Basel, Switzerland), Annick Goergler (Colmar, France) and Eric Andre Kusznir (Basel, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides heterocyclic compounds that bind to the ubiquitously expressed E3 ligase protein cereblon (CRBN) and their use for the treatment of abnormal cellular proliferation in a human or other host. The present invention also provides compounds that can be used as synthet...